Login to Your Account



Vernalis, Novartis Collaborate On Hsp90 Program In Cancer

By Nuala Moran


Wednesday, August 11, 2004
LONDON - Vernalis plc completed a trilogy of deals, announcing an Hsp90 cancer research collaboration with the Novartis Institute for Biomedical Research to add to recent agreements with Biogen Idec Inc. and Endo Pharmaceuticals Inc. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription